Influenza A viruses (lAV) and Ebola viruses (EBOV) are negafive-sense RNA viruses that cause human infecfions associated with respiratory disease or hemorrhagic fever, respectively. Both viruses have small genomes, encoding only 11-12 (lAV) or 8 (EBOV) known viral proteins;however, the idenfification of novel proteins in recent years suggests that these viruses may encode additional uncharacterized genes that are transcribed or transcribed/translated, via non-conventional strategies. We hypothesize that these genes and their products likely contribute to the viral life cycle. Therefore, the goal of research project 2 (RP 2) is to identify and determine the functions of uncharacterized lAV and EBOV genes. In Aini 1, we will experimentally prove that hypothetical genes can be expressed from the genomes of lAV and EBOV at the protein level. For all uncharacterized gene categories;1) proven hypothefical gene candidates, 2) unknown open reading frame candidates (i.e., viral proteins already known to be expressed but not yet functionally characterized), and 3) noncoding viral RNA candidates, we will assess the biochemical function of these uncharacterized gene candidates, including using apoptosis assays in our laboratory. Additional biochemical assays will be perfonned in RP 1 - Baric to examine the role of uncharacterized genes in interferon and tolllike receptor signaling and in RP 3 - Damania to examine the role of uncharacterized genes in inflammasome and p53 signaling. Collecfively, all three RPs will contribute various assays to determine the biochemical funcfion of the uncharacterized genes in this proposal. By using reverse genefics techniques developed in our laboratory for lAV and EBOV, we will generate mutant viruses that no longer encode the uncharacterized gene product. We will then compare the growth kinetics and host responses to infection of wild-type virus and mutant viruses in cell culture (Aim 2) and in a mouse model (Aim 3). In addition, we will perform confocal microscopy imagining (Aim 2) to determine the subcellular localization of the potentially novel lAV and EBOV gene products, and also of potentially novel SARS coronavirus (RP 1) and human herpesviruses-8 (RP 3) gene products. Such microscopy studies will aid in determining the function of these

Public Health Relevance

Influenza A virus (lAV) and Ebola virus (EBOV) are classified as Category C and Category A priority agents, respectively, by the Nafional Institute of Allergy and Infectious Diseases (NIAID). Despite encoding only 11- 12 (lAV) or8 (EBOV) known viral proteins, both vinjses can cause severe, somefimes fatal infections in humans. Here, we seek to idenfify and determine the function of uncharacterized lAV and EBOV genes in an effort to identify new viral targets for therapeutic development.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program--Cooperative Agreements (U19)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Chapel Hill
United States
Zip Code
Graham, Rachel L; Deming, Damon J; Deming, Meagan E et al. (2018) Evaluation of a recombination-resistant coronavirus as a broadly applicable, rapidly implementable vaccine platform. Commun Biol 1:179
Oishi, Kohei; Yamayoshi, Seiya; Kozuka-Hata, Hiroko et al. (2018) N-Terminal Acetylation by NatB Is Required for the Shutoff Activity of Influenza A Virus PA-X. Cell Rep 24:851-860
Oishi, Kohei; Yamayoshi, Seiya; Kawaoka, Yoshihiro (2018) Identification of novel amino acid residues of influenza virus PA-X that are important for PA-X shutoff activity by using yeast. Virology 516:71-75
Johnson, Bryan A; Graham, Rachel L; Menachery, Vineet D (2018) Viral metagenomics, protein structure, and reverse genetics: Key strategies for investigating coronaviruses. Virology 517:30-37
Halfmann, Peter; Hill-Batorski, Lindsay; Kawaoka, Yoshihiro (2018) The Induction of IL-1? Secretion Through the NLRP3 Inflammasome During Ebola Virus Infection. J Infect Dis 218:S504-S507
Corcoran, Kathleen; Sherrod, Carly J; Perkowski, Ellen F et al. (2017) Genome Sequences of Diverse Human Cytomegalovirus Strains with Utility in Drug Screening and Vaccine Evaluation. Genome Announc 5:
Di, Han; Madden Jr, Joseph C; Morantz, Esther K et al. (2017) Expanded subgenomic mRNA transcriptome and coding capacity of a nidovirus. Proc Natl Acad Sci U S A 114:E8895-E8904
Widman, Douglas G; Young, Ellen; Yount, Boyd L et al. (2017) A Reverse Genetics Platform That Spans the Zika Virus Family Tree. MBio 8:
Gallichotte, Emily N; Dinnon 3rd, Kenneth H; Lim, Xin-Ni et al. (2017) CD-loop Extension in Zika Virus Envelope Protein Key for Stability and Pathogenesis. J Infect Dis 216:1196-1204
Menachery, Vineet D; Graham, Rachel L; Baric, Ralph S (2017) Jumping species-a mechanism for coronavirus persistence and survival. Curr Opin Virol 23:1-7

Showing the most recent 10 out of 44 publications